Anika Expects Busy 2019 Will Spur Massive 2020 Growth

Anika Therapeutics reported 4Q19 orthopedic revenue of USD $26 million, +9.5% vs. 4Q18, with full-year 2019 revenue of $101 million, +8% vs. 2018. The company made significant progress in 2019 on its transformation to a global commercial organization. Anika launched its first surgical orthopedic product, TACTOSET, in December 2019 and...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us